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Abstract
Background: Clinical immunity to malaria in human populations is developed after repeated exposure to malaria.
Regulation and balance of host immune responses may lead to optimal immunity against malaria parasite
infection. Polysaccharides (ABPS) derived from the Chinese herb ox knee Achyranthes bidentata possess immuno-
modulatory functions. The aim of this study is to use the rodent malaria model Plasmodium yoelii 17XL (P. y17XL)
to examine whether pretreatment with ABPS will modulate host immunity against malaria infection and improve
the outcome of the disease.
Methods: To determine whether ABPS could modulate immunity against malaria, mice were pretreated with ABPS
prior to blood-stage infection by P. y17XL. Host survival and parasitaemia were monitored daily. The effect of
pretreatment on host immune responses was studied through the quantitation of cytokines, dendritic cell
populations, and natural regulatory T cells (Treg).
Results: Pretreatment with ABPS prior to infection significantly extended the survival time of mice after P. y17XL
infection. At three and five days post-infection, ABPS pretreated mice developed stronger Th1 immune responses
against malaria infection with the number of F4/80
+CD36
+ macrophages and levels of IFN-g, TNF-a and nitric oxide
being significantly higher than in the control group. More importantly, ABPS-treated mice developed more myeloid
(CD11c
+CD11b
+) and plasmacytoid dendritic cells (CD11c
+CD45R
+/B220
+) than control mice. ABPS pretreatment
also resulted in modulated expression of MHC-II, CD86, and especially Toll-like receptor 9 by CD11c
+ dendritic cells.
In comparison, pretreatment with ABPS did not alter the number of natural Treg or the production of the anti-
inflammatory cytokine IL-10.
Conclusion: Pretreatment with the immuno-modulatory ABPS selectively enhanced Th1 immune responses to
control the proliferation of malaria parasites, and prolonged the survival of mice during subsequent malaria
infection.
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Malaria is a serious infectious disease caused by proto-
zoan parasites of the genus Plasmodium.W o r l d w i d e ,
there are estimated 200-300 million malaria cases
annually, causing approximately one million deaths,
mainly in children [1]. The fatalities are normally asso-
ciated with severe malaria involving life-threatening
complications such as acute respiratory distress, meta-
bolic acidosis and cerebral malaria. Despite treatment
with the best available anti-malarial drugs and suppor-
tive care, severe malaria is fatal in 10-30% of patients
[2,3]. Additional adjunctive management strategies are
being considered to reduce the severity of disease.
In endemic areas, repeated exposure to malaria infec-
tion results in the development of clinical immunity to
disease, which is characterized by low parasitaemia
levels rather than sterilizing immunity. Therefore, the
primary focus of malaria vaccines is to reduce morbidity
and mortality associated with this disease. Better under-
standing of host immunity against malaria is needed to
achieve this goal. Immunity to asexual blood stages of
malaria parasites involves both cellular and antibody-
mediated mechanisms [4]. Although cell-mediated
immune responses play the major role in protection
against parasite replication, they also result in detrimen-
tal inflammation and contribute to induction of severe
disease. CD4
+ T cells govern the cell-mediated immune
response to malaria parasites through the production of
cytokines. Pro-inflammatory (Th1) and anti-inflamma-
tory (Th2) cytokines produced by CD4
+ T cells play
decisive roles in the outcome of malaria infections. Early
pro-inflammatory cytokine responses seem to mediate
protective immunity, whereas late in infection they
appear to contribute to pathology [5]. In mice, the anti-
inflammatory cytokine IL-10, produced by natural regu-
latory T cells (Treg), is required to limit pro-inflamma-
tory immune responses [5-7]. Meanwhile, as the
pacemaker of the immune response, dendritic cells
(DCs) provide a source of cytokines that contribute to
shaping up cell-mediated and humoral immunity by
inducing Th1/Th2 differentiation of T cells and anti-
body production by B cells [8,9]. In addition to DCs,
another important effector molecule in malaria is the
toxic free radical NO, which is widely recognized as an
important biological mediator [10]. In the context of an
acute inflammatory disease, such as malaria, much of
the NO produced comes from the cytokine inducible
NO synthase (iNOS) present in monocytes, macro-
phages, and neutrophils [11]. Pro-inflammatory cyto-
kines (e.g. IFN-g and TNF-a) increase iNOS-generated
NO production, whereas anti-inflammatory cytokines (e.
g. IL-10 and TGF-b)d o w n - r e g u l a t eN O S 2e x p r e s s i o n
[11]. NO also has been reported to have potent
parasiticidal properties against P. falciparum [12] and
can thereby limit parasitaemia [13]. These findings high-
light the significance of a crucial balance in the inflam-
matory response for controlling infection and preventing
pathology in malaria. Thus, regulation of host immune
responses may lead to enhanced immunity against
malaria parasite infection.
Polysaccharides are high molecular weight compounds
formed by repeating sub-units of sugars, which are
widely distributed in plants, animals and microbes
[14-16]. Polysaccharides have been shown to possess
anti-tumour, anti-hepatitis and anti-senile effects, as
well as immunomodulatory functions, such as stimulat-
ing splenocyte proliferation while in combination with
LPS, activating macrophage, NK T cells, B cells and
maturation of DCs [17,18]. Ox knee (Achyranthes biden-
tata) is a traditional Chinese medicinal herb, which has
anti-inflammatory activities and is used to “nourish the
kidney and liver, drain dampness and promote circula-
tion”.T h ep u r i f i e dA. bidentata polysaccharides (ABPS)
are water-soluble molecules with its unit composition
molecular weight of ~1400 D, and contain fructose and
glucose residues in the molar ratio of 8:1. ABPS are
bioactive and have many important functions such as
anti-tumour, anti-inflammation and anti-aging [19-22].
The immuno-modulatory effect of ABPS has prompted
us to investigate whether pretreatment with ABPS
affects the host immunity against malaria infection.
Here, the murine malaria model was used with the
lethal strain of Plasmodium yoelii 17XL (P. y17XL). In
this model, mice are unable to establish an effective Th1
response and die during the early stages of infection
[23,24]. The results indicated that pretreatment with
ABPS could boost host Th1 response against the para-
site and prolong the survival of infected mice.
Methods
Mice, parasites and experimental infection
Female BALB/c mice, aged six to eight weeks, were pur-
chased from Beijing Animal Institute (Beijing, China). P.
y17XL parasitized erythrocytes were purified as pre-
viously described [25]. To initiate malaria infection, each
mouse was injected intraperitoneally (i.p.) with 1 × 10
6
P. y17XL parasitized erythrocytes per mouse. Parasitae-
mia was monitored by light microscopy. Mortality of
infected mice was monitored daily. All experiments
were performed in compliance with the local Institu-
tional Animal Care and Use Committee.
ABPS treatment
White powder ABPS with 99% purity was kindly pro-
vided by Gengyuan Tian of Shanghai Institute of
Organic Chemistry, Chinese Academy of Sciences,
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pared with physiological saline. To study the effect of
ABPS on parasitaemia and host survival, 0.1 ml ABPs
solutions were injected i.p. daily into mice at the dosage
of 50 mg/kg for consecutive 10 and 15 days before or
immediately after P.y17XL infection. This dosage was
adopted based on an earlier report, which shows that 50
mg/kg of ABPS is optimal against Lewis lung cancer in
C57BL/6 mice [22]. The control group received the
same volume of physiological saline at the same time
points. Subsequently, to study the immuno-modulatory
effect of ABPS, two dosages of ABPS (10 and 50 mg/kg)
were used for i.p. injection daily into the mice for conse-
cutive 10 days before infection [22,26].
Splenocyte preparation, culture and measurement of
cytokines and nitric oxide
Splenocyte culture was performed as previously
described [27]. Briefly, spl e e n sf r o mu n i n f e c t e da n d
infected mice were removed aseptically and pressed
through a sterile fine-wire mesh with 10 ml RPMI 1640
supplemented with 10% heat-inactivated foetal calf
s e r u m( F C S ) ,2 5m MH e p e s ,0 . 1 2 %g e n t a m i c i na n d2
mM glutamine. Cell suspensions were collected by cen-
trifuging at 350 g for 10 minutes. Cell viability was
determined by Trypan Blue exclusion and was > 90%.
Aliquots of the cell suspensions containing 5 × 10
6 cells
in 500 μl were incubated in 24-well flat-bottom tissue
culture plates in triplicate for 48 hours at 37°C in a
humidified 5% CO2 incubator. Supernatant fractions
were collected and stored at -80°C. Levels of IFN-g,
TNF-a and IL-10 were measured by commercial
enzyme-linked immuno-sorbent assay (ELISA) kits
according to the manufacturer’s protocol (R&D Sys-
tems). As a measure of nitric oxide (NO) production,
concentrations of NO2
- in cell supernatants were deter-
mined by the Griess reaction [27].
Flow cytometry analysis
All antibodies used for flow cytometry were purchased
from BD Biosciences or eBioscience (San Diego, CA,
USA) unless otherwise indicated. To assess natural
Treg, spleen cells were double-stained with FITC-conju-
gated anti-CD4 monoclonal antibody (mAb) and PE-
conjugated anti-CD25 mAb. After fixation and permea-
bilization, cells were stained with APC-conjugated anti-
Foxp3 mAb. To distinguish the sub-sets of DCs, spleen
cells were double-stained with FITC-conjugated anti-
CD11c mAb and PE-conjugated anti-CD11b mAb or
PerCP-conjugated anti-B220 mAb. To measure the
maturation markers of DCs, spleen cells were double-
stained with FITC-conjugated CD11c mAb and PE-con-
jugated anti-CD80, CD86, CD40 or MHC-II mAb. To
determine the expression of Toll-like receptor 9 (TLR9)
within DCs, spleen cells were first stained with FITC-
conjugated CD11c mAb, fixed, permeabilized and
probed with biotinylated anti-TLR9 mAb followed by
PE-conjugated streptavidin. Macrophages were analysed
by staining spleen cells with FITC-conjugated F4/80
mAb and/or PE-conjugated anti-CD36 mAb. After stain-
ing, the cells were washed twice with PBS containing 1%
foetal calf serum and suspended in 500 μlo fP B S .A l l
cells were analysed by flow cytometry using a FACSCali-
bur™ flow cytometer with the CellQuest software ver-
sion 3.3 (BD Biosciences, Franklin Lakes, NJ, USA).
Viable cells were gated by forward and side scattering
[28,29].
Statistical analysis
Statistical significance of the results was analysed by
one-way ANOVA. Time-to-event data were statistically
analysed with the Kaplan-Meier approach to survival
analysis (SPSS 17.0). A value of P < 0.05 was considered
significant.
Results
ABPS extends survival of Plasmodium
yoelii 17XL infected mice
To determine the effects of ABPS on P.y17XL infection
in BALB/c mice, parasitaemia and survival rate were
monitored daily after infection. In the control group,
parasitaemia rose sharply to >50% on day 5 and ~60%
on day 7, and all mice died of high parasitaemia at five
to seven days post-infection (dpi) (Figure 1), consistent
with our previous reports [24,30]. In all ABPS-treated
groups, parasitaemia on day 5 was significantly lower
than that of the control group (P < 0.05). In mice trea-
ted with ABPS for 10 and 15 days, parasitaemia also
peaked on day 7, but declined subsequently (Figure 1A).
Whereas all mice treated with ABPS at the time of
infection died from high parasitaemia at 8 dpi, pretreat-
ment with ABPS prior to malaria infection significantly
extended the survival time of infected mice (P < 0.01,
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Figure 1 Effects of pretreatment with ABPS on parasitaemia
(A) and survival rate (B) of infected mice. ABPS was injected i.p.
into mice at the dosage of 50 mg/kg for consecutive 10 (10 d) or
15 days (15 d) before and immediately after (0 d) P.y17XL infection.
The control group (NC) received the same volume of physiological
saline at the same time points. Data presented as the mean with
standard error (n = 10 mice per group)
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survived at 19 and 23 dpi in groups pretreated with
ABPS for 10 and 15 days, respectively (Figure 1B). This
result showed that pretreatment with ABPS before infec-
tion with P.y17XL could suppress the progression of
malaria in BALB/c mice. Based on this result, all subse-
quent immunology experiments used the treatment time
of 10 days before infection and dosages of 10 and 50
mg/kg of ABPS.
ABPS have immuno-regulatory effects on adaptive
immune responses
The effects of ABPS pretreatment on adaptive immune
responses were investigated during early infection by P.
y17XL in BALB/c mice. Although ABPS pretreatment
did not significantly alter the number of splenocytes
(Figure 2A), it caused a remarkable induction of IFN-g
at 3 dpi (Figure 2B), and TNF-a at 3 and 5 dpi as com-
pared to the control group (Figure 2C, P <0 . 0 5 ) .
Whereas the number of F4/80
+macrophages did not dif-
fer remarkably between the ABPS-treated and control
groups (Figure 2D), there were significantly more F4/80
+CD36
+ macrophages in the ABPS-treated groups at 3
dpi (Figure 2E). As a result, in the ABPS-treated groups,
NO synthesis was also significantly increased at 5 dpi
(P < 0.05, Figure 2F).
ABPS do not affect the response of natural Treg cells
during Plasmodium yoelii 17XL infection
To elucidate how ABPS activated the immune response,
the potential regulation of response of natural Treg by
ABPS during activation of immune responses was inves-
tigated in vivo. Previous studies have shown that prolif-
eration of Treg is causally associated with the
suppression of Th1 responses during early malaria infec-
tion, leading to increased parasitaemia and mortality in
mice [30]. In control mice, the absolute number of nat-
ural Treg increased from 5 × 10
5 at 3 dpi to 2 × 10
6 at
5 dpi. This increase of Treg population was not signifi-
cantly affected by pretreatment with ABPS (P >0 . 0 5 ,
Figure 3A). Similarly, pretreatment with ABPS did not
affect the production of IL-10 (P > 0.05, Figure 3B)
ABPS increase TLR9 expression in CD11c
+ DCs
Since ABPS had no effect on the percentage of natural
Treg, the effects of ABPS on DCs, which are essential
for the induction of T cell responses, were examined. In
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Figure 2 T h ee f f e c t so fA B P Sp r e t r e a t m e n to ni m m u n e
responses during early Plasmodium yoelii 17XL (P. y17XL)
infection. Mice were injected i.p. with two different dosages of
ABPS (10 mg/kg and 50 mg/kg) for consecutive 10 days prior to
infection, and spleen lysates were prepared on days 0, 3 and 5 after
infection. The control group (NC) received the same volume of
physiological saline at the same time points. (A) Total number of
splenocytes per mouse. (B) Levels of IFN-g (C) Levels of TNF-a (D)
Total number of F4/80
+ macrophages. (E) Total number of CD36+
macrophages. (F) Concentration of NO2-. Values represent the mean
with standard error (n = 3 mice per group). Results are
representative of three independent experiments. Asterisk (*)
indicates statistically significant difference (P < 0.05) between the
control and ABPS pretreated groups of mice. Open, grey and black
boxes indicate control group (NC), 10 mg/kg ABPS group (10 mg),
and 50 mg/kg ABPS group (50 mg), respectively
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natural Treg. (A) Numbers of Treg (CD4
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+Foxp3
+) cells in the
spleens of infected and control mice quantified by flow cytometry.
(B) Spleen cell culture suspensions were collected on different days
after infection and levels of IL-10 protein were measured by ELISA.
Data presentation is the same as in Figure 2
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increases (P < 0.05) in the proportions of myeloid DCs
(mDCs) and plasmocytoid DCs (pDCs) (Figure 4A, B).
Whereas pretreatment with ABPS did not affect the
expression of CD40 or CD80 (Figure 4C), it significantly
enhanced the expression of DC maturation markers
CD86 (Figure 4D) and MHC II (Figure 4E) on DCs.
Strikingly, the results showed that ABPS treatment sig-
nificantly increased the expression of TLR9 by DCs (P <
0.05, Figure 4F).
Discussion
The Chinese herbal medicine ox knee (A. bidentata)
possesses pro-inflammatory activities, and polysacchar-
ides from this herb have been shown to enhance immu-
nity [19]. This study demonstrated that pretreatment
with ABPS could delay the progression of malaria in
mice, probably through boosting of host immunity. It
was also found that ABPS could effectively control para-
sitaemia levels and extend host survival. ABPS treatment
enhanced the production of IFN-g,T N F - a and NO, and
increased the number of F4/80
+CD36
+ macrophages.
ABPS also promoted the differentiation and activation
of DCs with increased expression of maturation mar-
kers. This study further verified the immuno-modulatory
activity of ABPS during the early stage of P.y17XL
infection in this murine malaria model, which provided
some insights into the regulatory mechanisms by which
ABPS mediate anti-malarial protection.
During malaria infection, effective Th1 immune
responses at the early stages of infection critically influ-
ence the later development and final outcome of the
disease [31-34]. IFN-g is found to be necessary during
the resolution of primary infection and for limiting para-
site replication in early phase of the infection [35,36]. In
current study, it was found that pretreatment with
ABPS significantly stimulated IFN-g,T N F - a and NO
production in vivo during P.y17XL infection, which
might be responsible for the observed improvement in
the extended survival in ABPS-treated mice.
DCs provide a critical link between the innate and
adaptive immune responses. Increased expression of
co-stimulatory molecules, which is characteristic of
maturation of DCs, is crucial to the activation of T
cells [37]. These molecules have been shown to play
an important role in murine malaria models. High
expression of MHC-II molecules is crucial for DCs to
present antigens to CD4
+ T cells. It has been found
that blocking the CD80/CD86 signaling pathway dis-
rupts the Th1/Th2 balance in the Plasmodium cha-
baudi AS malaria model [38]. It is reported that ABPS
can induce murine DCs phenotypic maturation in vitro
as revealed by increased expression of CD86, CD40
and MHC-II [18]. In this study, the significant up-reg-
ulation of co-stimulatory molecules on the surface of
CD11c
+ cells in ABPS-treated mice was detected, indi-
cating that ABPS treatment could significantly improve
the maturation of DCs.
TLRs are expressed on or within innate immune
cells including DCs, and recognize pathogen-asso-
ciated molecular patterns from different microorgan-
isms [39]. Accumulating evidence suggests that TLRs
are also involved in both rodent and human malaria
[40-42]. It has been reported that TLR9 responds to
haemozoin and parasite protein-DNA complex
released from the parasitized erythrocytes [41,43,44],
and TLR9 polymorphisms are associated with disease
manifestation in malaria [37]. The significantly ele-
vated expression of TLR9 in DCs in P.y17XL-infected
mice pretreated with ABPS suggests that TLR9 might
be essential for ABPS-mediated immuno-regulation
during malaria infection.
Increasing evidence indicates that innate immune
responses contribute to the control of blood-stage
malaria infection, reduced parasite burden, and slowing
down of the progression to severe disease. Macrophages
have a remarkable non-specific ability to phagocytize
and kill protozoan parasites. Both human and rodent
macrophages effectively phagocytize P.y17XL-parasitized
erythrocytes [45,46]. Furthermore, the class B family of
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implied in protection against malaria, since CD36-defi-
cient individuals are at a greater risk of developing
severe and cerebral malaria [47]. Whereas the total
number of macrophages (F4/80
+) in ABPS-pretreated
mice was relatively unchanged, the number of F4/80
+CD36
+ macrophages significantly increased at 3 dpi in
ABPS pretreated mice. As such, the increase in the
number of CD36
+ macrophages might be involved in
phagocytosis of parasitized erythrocytes, leading to
reduced parasitaemia at 5 dpi in ABPS-pretreated mice.
Natural Treg expand during Plasmodium infection
[5,24,48,49] and have been shown to inhibit the develop-
ment of Th1 immune responses [3,24], leading to persis-
tent rise of parasitaemia [24,50]. Here it was found that
ABPS only improved the activation of DCs, which may
improve the initiation of an antigen-specific immune
response, whereas no effect was observed on Treg or
production of the anti-inflammatory cytokine IL-10.
This suggests that the immuno-regulatory effects of
ABPS may be selective on boosting different host
immune responses.
Taken together, the current study further confirmed
the immuno-regulatory effects of ABPS. The results
have demonstrated that ABPS could activate immune
responses against malaria blood-stage infection in mice
and that this effect may be mediated by stimulation of
DC maturation and activation of F4/80
+CD36
+ macro-
phages, which may phagocytose parasitized erythrocytes
and release pre-inflammatory cytokines. These findings
laid the foundation for further testing the potential ben-
efits of administering ABPS as an “immuno-prophylaxis”
to inhibit preemptively the progression of malaria
infection.
Conclusions
The aim of this study is to determine whether pre-
treatment of hosts with immuno-modulatory polysac-
charides from the Chinese medicinal herb ox knee,
could affect host immunity during malaria infection
in a rodent malaria model. It was found that pretreat-
ment of mice with ABPS could boost host Th1
immune responses during early P.y17XL infection,
which includes elevated numbers of activated macro-
phages and Th1 cytokines. In addition, ABPS pre-
treatment promoted the maturation of DCs, which
are essential in development of parasite-specific adap-
tive immunity. Yet, the treatment did not alter the
number of Treg and the level of anti-inflammatory
cytokine IL-10. Findings from this study underscore
the potential of administering immuno-modulatory
compounds like ABPS to strengthen host immunity
against malaria.
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